Dr. Agarwal's Eye [DRAGARWQ] vs KMC Speciality [KMCSHIL] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Dr. Agarwal's Eye Hospital Ltd. wins in 9 metrics, KMC Speciality Hospitals India Limited wins in 10 metrics, with 0 ties. KMC Speciality Hospitals India Limited appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Dr. Agarwal's Eye Hospital Ltd. | KMC Speciality Hospitals India Limited | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 34.01 | 40.06 | Dr. Agarwal's Eye Hospital Ltd. |
| Price-to-Book Ratio | 7.52 | 8.09 | Dr. Agarwal's Eye Hospital Ltd. |
| Debt-to-Equity Ratio | 106.45 | 47.30 | KMC Speciality Hospitals India Limited |
| PEG Ratio | 1.81 | 0.48 | KMC Speciality Hospitals India Limited |
| EV/EBITDA | 20.64 | 19.02 | KMC Speciality Hospitals India Limited |
| Profit Margin (TTM) | 15.50% | 12.88% | Dr. Agarwal's Eye Hospital Ltd. |
| Operating Margin (TTM) | 19.54% | 23.66% | KMC Speciality Hospitals India Limited |
| EBITDA Margin (TTM) | 19.54% | 23.66% | KMC Speciality Hospitals India Limited |
| Return on Equity | 26.07% | 13.04% | Dr. Agarwal's Eye Hospital Ltd. |
| Return on Assets (TTM) | 8.91% | 7.49% | Dr. Agarwal's Eye Hospital Ltd. |
| Free Cash Flow (TTM) | $-83.80M | $-62.99M | KMC Speciality Hospitals India Limited |
| Dividend Yield | 0.11% | N/A | N/A |
| 1-Year Return | 12.35% | 75.08% | KMC Speciality Hospitals India Limited |
| Price-to-Sales Ratio (TTM) | 5.39 | 5.14 | KMC Speciality Hospitals India Limited |
| Enterprise Value | $26.69B | $15.31B | Dr. Agarwal's Eye Hospital Ltd. |
| EV/Revenue Ratio | 5.92 | 5.38 | KMC Speciality Hospitals India Limited |
| Gross Profit Margin (TTM) | 78.09% | 86.05% | KMC Speciality Hospitals India Limited |
| Revenue per Share (TTM) | $952 | $17 | Dr. Agarwal's Eye Hospital Ltd. |
| Earnings per Share (Diluted) | $147.68 | $2.24 | Dr. Agarwal's Eye Hospital Ltd. |
| Beta (Stock Volatility) | -0.57 | -0.13 | Dr. Agarwal's Eye Hospital Ltd. |
Dr. Agarwal's Eye Hospital Ltd. vs KMC Speciality Hospitals India Limited Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Dr. Agarwal's Eye Hospital Ltd. | 0.58% | 0.12% | -1.62% | 6.94% | -8.52% | -6.31% |
| KMC Speciality Hospitals India Limited | 0.51% | 5.86% | 25.78% | 46.86% | 57.94% | 48.70% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Dr. Agarwal's Eye Hospital Ltd. | 12.35% | 240.02% | 1,131.89% | 2,480.68% | 5,282.48% | 17,498.05% |
| KMC Speciality Hospitals India Limited | 75.08% | 79.95% | 209.93% | 1,499.87% | 6,792.44% | 34,767.65% |
Performance & Financial Health Analysis: Dr. Agarwal's Eye Hospital Ltd. vs KMC Speciality Hospitals India Limited
| Metric | DRAGARWQ | KMCSHIL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹24.28B | ₹14.64B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,256 | 80,768 |
| 90 Day Avg. Volume | 1,378 | 66,406 |
| Last Close | ₹4,991.20 | ₹119.15 |
| 52 Week Range | ₹4,142.00 - ₹6,392.00 | ₹62.50 - ₹124.85 |
| % from 52W High | -21.91% | -4.57% |
| All-Time High | ₹7,300.00 (Dec 30, 2024) | ₹124.85 (Jun 03, 2026) |
| % from All-Time High | -31.63% | -4.57% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.22% | 0.34% |
| Quarterly Earnings Growth | 0.66% | 0.83% |
| Financial Health | ||
| Profit Margin (TTM) | 0.16% | 0.13% |
| Operating Margin (TTM) | 0.20% | 0.24% |
| Return on Equity (TTM) | 0.26% | 0.13% |
| Debt to Equity (MRQ) | 106.45 | 47.30 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹668.22 | ₹11.09 |
| Cash per Share (MRQ) | ₹191.98 | ₹1.82 |
| Operating Cash Flow (TTM) | ₹738.70M | ₹362.55M |
| Levered Free Cash Flow (TTM) | ₹546.50M | ₹214.27M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.11% | N/A |
| Last 12-Month Dividend | ₹5.00 | N/A |
Valuation & Enterprise Metrics Analysis: Dr. Agarwal's Eye Hospital Ltd. vs KMC Speciality Hospitals India Limited
| Metric | DRAGARWQ (Apr 26, 2026) | KMCSHIL (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 34.01 | 40.06 |
| Forward P/E | 516.77 | N/A |
| PEG Ratio | 1.81 | 0.48 |
| Price to Sales (TTM) | 5.39 | 5.14 |
| Price to Book (MRQ) | 7.52 | 8.09 |
| Market Capitalization | ||
| Market Capitalization | ₹24.28B | ₹14.64B |
| Enterprise Value | ₹26.69B | ₹15.31B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.92 | 5.38 |
| Enterprise to EBITDA | 20.64 | 19.02 |
| Risk & Other Metrics | ||
| Beta | -0.57 | -0.13 |
| Book Value per Share (MRQ) | ₹668.22 | ₹11.09 |
Financial Statements Comparison: Dr. Agarwal's Eye Hospital Ltd. vs KMC Speciality Hospitals India Limited
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | DRAGARWQ (2025) | KMCSHIL (2025) |
|---|---|---|
| Revenue/Sales | 3.94B | 2.29B |
| Cost of Goods Sold | 896.20M | 336.77M |
| COGS % of Revenue | 22.8% | 14.7% |
| Gross Profit | 3.04B | 1.96B |
| Gross Margin | 77.2% | 85.3% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 813.30M | 386.65M |
| Operating Margin | 20.6% | 16.9% |
| EBITDA | 1.22B | 600.92M |
| EBITDA Margin | 31.1% | 26.2% |
| Pre-Tax Income | 707.00M | 316.03M |
| Pre-Tax Income % of Revenue | 17.9% | 13.8% |
| Income Tax | 160.50M | 101.76M |
| Income Tax % of Revenue | 4.1% | 4.4% |
| Net Income (Profit) | 546.50M | 214.27M |
| Profit Margin | 13.9% | 9.3% |
Balance Sheet & Liquidity Metrics
| Metric | DRAGARWQ (2025) | KMCSHIL (2025) |
|---|---|---|
| Cash & Equivalents | 111.60M | 91.90M |
| Total Current Assets | 559.40M | 332.41M |
| Total Current Assets % of Revenue | 14.2% | 14.5% |
| Total Current Liabilities | 869.80M | 379.41M |
| Total Current Liabilities % of Revenue | 22.1% | 16.5% |
| Long-Term Debt | 3.06B | 778.48M |
| Long-Term Debt % of Revenue | 77.6% | 33.9% |
| Total Shareholders Equity | 2.10B | 1.64B |
| Retained Earnings | 1.99B | 1.50B |
| Retained Earnings % of Revenue | 50.4% | 65.3% |
| Property, Plant & Equipment | 1.37B | 976.56M |
Cash Flow Statement Comparison
| Metric | DRAGARWQ (2025) | KMCSHIL (2025) |
|---|---|---|
| Operating Cash Flow | 738.70M | 362.55M |
| Operating Cash Flow % of Revenue | 18.8% | 15.8% |
| Capital Expenditures | 4.10M | -638.72M |
| Free Cash Flow | -83.80M | -62.99M |
| FCF Margin | -2.1% | -2.7% |
| Debt Repayment | -111.30M | -91.57M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DRAGARWQ | KMCSHIL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 4.83M | 163.09M |
| Float Shares | 1.08M | 36.79M |
| % Held by Insiders | 77.59% | 77.49% |
| % Held by Institutions | 3.57% | 0.00% |
| % Held by Public | 18.84% | 22.51% |
Dividend Analysis & Yield Comparison: Dr. Agarwal's Eye Hospital Ltd. vs KMC Speciality Hospitals India Limited
| Metric | DRAGARWQ | KMCSHIL |
|---|---|---|
| Last 12-Month Dividend | ₹5.00 | N/A |
| Last 12-Month Dividend Yield | 0.11% | N/A |
| 3-Year Avg Annual Dividend | ₹4.50 | N/A |
| 3-Year Avg Dividend Yield | 0.12% | N/A |
| 3-Year Total Dividends | ₹13.50 | N/A |
| Ex-Dividend Date | Nov 08, 2024 | N/A |